Elad Aharonson on financial guidance
From ICL Investor Day October 2022 · · ICL Group
“We are targeting more than two billion dollar specialty ebitda business up 100 with a keger of 16 percent... we are targeting sales of 13 billion dollars that's 11 keger and ebida margin of 28 percent that's 13 keger by 2027.”
On , Elad Aharonson, President & CEO at ICL Group, spoke about financial guidance during ICL Investor Day October 2022 on ICL Group.
About Elad Aharonson
At ICL's October 2022 Investor Day, President and CEO Elad Aharonson stated that the company had already reached its 2025 targets two years early, attributing this to successful acquisitions in Brazil and their integration. He noted that Brazil, China, and India account for 70 percent of growth in the specialty plant nutrition market, and said ICL is focused on those countries. Aharonson outlined new targets for 2027, aiming for $4.25 billion in sales and EBITDA of more than $750 million, with the goal of becoming the global leader in specialty plant nutrition. He also said that in a normal year, EBITDA would track around 15 percent, with the underlying business growing margins over time despite commodity impacts.